The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration
Open accessAbstract
Ewing sarcoma (ES) is an aggressive sarcoma of bone and soft tissue occurring at any age with a peak incidence in adolescents and young adults. The treatment of ES relies on a multidisciplinary approach, coupling risk-adapted intensive neoadjuvant and adjuvant chemotherapies with surgery and/or radiotherapy for control of the primary site and possible metastatic disease. The optimization of ES multimodality therapeutic strategies has resulted from the efforts of several national and international groups in Europe and North America and from cooperation between pediatric and medical oncologists. Successive first-line trials addressed the efficacy of various cyclic combinations of drugs incorporating doxorubicin, vincristine, cyclophosphamide, ifosfamide, etoposide, and dactinomycin and identified prognostic factors now used to tailor therapies. The role of high-dose chemotherapy is still debated. Current 5-year overall survival for patients with localized disease is 65% to 75%. Patients with metastases have a 5-year overall survival < 30%, except for those with isolated pulmonary metastasis (approximately 50%). Patients with recurrence have a dismal prognosis. The many insights into the biology of the EWS-FLI1 protein in the initiation and progression of ES remain to be translated into novel therapeutic strategies. Current options and future approaches will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
Self-citationGene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Self-citationGrier, H. E., Krailo, M. D., Tarbell, N. J., Link, M. P., Fryer, C. J. H., Pritchard, D. J., Gebhardt, M. C., Dickman, P. S., Perlman, E. J., Meyers, P. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020890 · Cited by 1,328
Womer, R. B., West, D. C., Krailo, M. D., Dickman, P. S., Pawel, B. R., Grier, H. E., Marcus, K., Sailer, S., Healey, J. H., Dormans, J. P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5703 · Cited by 757
Self-citationEwing, J. (1972) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.22.2.95 · Cited by 583
Tirode, F., Surdez, D., Ma, X., Parker, M., Le Deley, M. C., Bahrami, A., Zhang, Z., Lapouble, E., Grossetête-Lalami, S., Rusch, M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0622 · Cited by 565
Self-citationPrimary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial
Ladenstein, R., Pötschger, U., Le Deley, M. C., Whelan, J., Paulussen, M., Oberlin, O., van den Berg, H., Dirksen, U., Hjorth, L., Michon, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.9864 · Cited by 540
Self-citationEWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
de Alava, E., Kawai, A., Healey, J. H., Fligman, I., Meyers, P. A., Huvos, A. G., Gerald, W. L., Jhanwar, S. C., Argani, P., Antonescu, C. R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1248 · Cited by 524
Self-citationLocalized Ewing Tumor of Bone: Final Results of the Cooperative Ewing’s Sarcoma Study CESS 86
Paulussen, M., Ahrens, S., Dunst, J., Winkelmann, W., Exner, G. U., Kotz, R., Amann, G., Dockhorn-Dworniczak, B., Harms, D., Müller-Weihrich, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1818 · Cited by 445
Self-citationJürgens, H., Exner, U., Gadner, H., Harms, D., Michaelis, J., Sauer, R., Treuner, J., Voûte, T., Winkelmann, W., Winkler, K., et al. (1988) · Cancer · doi:10.1002/1097-0142(19880101)61:1<23::aid-cncr2820610106>3.0.co;2-m · Cited by 417
Burgert, E. O., Nesbit, M. E., Garnsey, L. A., Gehan, E. A., Herrmann, J., Vietti, T. J., Cangir, A., Tefft, M., Evans, R., & Thomas, P. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1514 · Cited by 380
Schuck, A., Ahrens, S., Paulussen, M., Kuhlen, M., Könemann, S., Rübe, C., Winkelmann, W., Kotz, R., Dunst, J., Willich, N., et al. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03797-5 · Cited by 348
Self-citationHardes, J., von Eiff, C., Streitbuerger, A., Balke, M., Budny, T., Henrichs, M. P., Hauschild, G., & Ahrens, H. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21498 · Cited by 337
Granowetter, L., Womer, R., Devidas, M., Krailo, M., Wang, C., Bernstein, M., Marina, N., Leavey, P., Gebhardt, M., Healey, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1478 · Cited by 330
Self-citationBacci, G., Ferrari, S., Bertoni, F., Rimondini, S., Longhi, A., Bacchini, P., Forni, C., Manfrini, M., Donati, D., & Picci, P. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.4 · Cited by 327
Self-citationZoubek, A., Dockhorn-Dworniczak, B., Delattre, O., Christiansen, H., Niggli, F., Gatterer-Menz, I., Smith, T. L., Jürgens, H., Gadner, H., & Kovar, H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1245 · Cited by 322
Self-citationRisk of recurrence and survival after relapse in patients with Ewing sarcoma
Stahl, M., Ranft, A., Paulussen, M., Bölling, T., Vieth, V., Bielack, S., Görtitz, I., Braun‐Munzinger, G., Hardes, J., Jürgens, H., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23040 · Cited by 315
Self-citationPARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma
Brenner, J. C., Feng, F. Y., Han, S., Patel, S., Goyal, S. V., Bou-Maroun, L. M., Liu, M., Lonigro, R., Prensner, J. R., Tomlins, S. A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3648 · Cited by 290
Hawkins, D. S., Schuetze, S. M., Butrynski, J. E., Rajendran, J. G., Vernon, C. B., Conrad, E. U., & Eary, J. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.7079 · Cited by 286
Self-citationJuergens, C., Weston, C., Lewis, I., Whelan, J., Paulussen, M., Oberlin, O., Michon, J., Zoubek, A., Juergens, H., & Craft, A. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20820 · Cited by 282
Self-citationPaulussen, M., Craft, A. W., Lewis, I., Hackshaw, A., Douglas, C., Dunst, J., Schuck, A., Winkelmann, W., Köhler, G., Poremba, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5720 · Cited by 263
Self-citationPaulussen, M., Ahrens, S., Craft, A. W., Dunst, J., Fröhlich, B., Jabar, S., Rübe, C., Winkelmann, W., Wissing, S., Zoubek, A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.3044 · Cited by 249
Self-citationSpecht, K., Sung, Y., Zhang, L., Richter, G. H. S., Fletcher, C. D., & Antonescu, C. R. (2014) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.22172 · Cited by 242
G�bel, V., J�rgens, H., Etsp�ler, G., Kemperdick, H., Jungblut, R. M., Stienen, U., & G�bel, U. (1987) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00391442 · Cited by 233
RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis
Wittrant, Y., Théoleyre, S., Chipoy, C., Padrines, M., Blanchard, F., Heymann, D., & Rédini, F. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.05.002 · Cited by 231
Schleiermacher, G., Peter, M., Oberlin, O., Philip, T., Rubie, H., Mechinaud, F., Sommelet-Olive, D., Landman-Parker, J., Bours, D., Michon, J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.006 · Cited by 210
Self-citationMeyers, P. A., Krailo, M. D., Ladanyi, M., Chan, K.-W., Sailer, S. L., Dickman, P. S., Baker, D. L., Davis, J. H., Gerbing, R. B., Grovas, A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2812 · Cited by 206
A multidisciplinary study investigating radiotherapy in Ewing’s sarcoma: end results of POG #8346
Donaldson, S. S., Torrey, M., Link, M. P., Glicksman, A., Gilula, L., Laurie, F., Manning, J., Neff, J., Reinus, W., Thompson, E., et al. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00191-6 · Cited by 205
Leavey, P. J., Mascarenhas, L., Marina, N., Chen, Z., Krailo, M., Miser, J., Brown, K., Tarbell, N., Bernstein, M. L., Granowetter, L., et al. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21618 · Cited by 204
Self-citationSmith, M. A., Ungerleider, R. S., Horowitz, M. E., & Simon, R. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.20.1460 · Cited by 202
Le Deley, M.-C., Delattre, O., Schaefer, K.-L., Burchill, S. A., Koehler, G., Hogendoorn, P. C. W., Lion, T., Poremba, C., Marandet, J., Ballet, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3585 · Cited by 199
Self-citationIrinotecan and temozolomide for Ewing sarcoma: The Memorial Sloan‐Kettering experience
Casey, D. A., Wexler, L. H., Merchant, M. S., Chou, A. J., Merola, P. R., Price, A. P., & Meyers, P. A. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22206 · Cited by 190
DuBois, S. G., Krailo, M. D., Gebhardt, M. C., Donaldson, S. S., Marcus, K. J., Dormans, J., Shamberger, R. C., Sailer, S., Nicholas, R. W., Healey, J. H., et al. (2015) · Cancer · doi:10.1002/cncr.29065 · Cited by 189
Self-citationLe Deley, M.-C., Paulussen, M., Lewis, I., Brennan, B., Ranft, A., Whelan, J., Le Teuff, G., Michon, J., Ladenstein, R., Marec-Bérard, P., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.4833 · Cited by 179
Self-citationCommon variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
Postel-Vinay, S., Véron, A. S., Tirode, F., Pierron, G., Reynaud, S., Kovar, H., Oberlin, O., Lapouble, E., Ballet, S., Lucchesi, C., et al. (2012) · Nature Genetics · doi:10.1038/ng.1085 · Cited by 176
Self-citationTopotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors
Hunold, A., Weddeling, N., Paulussen, M., Ranft, A., Liebscher, C., & Jürgens, H. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20719 · Cited by 168
Self-citationBacci, G., Forni, C., Longhi, A., Ferrari, S., Donati, D., De Paolis, M., Barbieri, E., Pignotti, E., Rosito, P., & Versari, M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.08.022 · Cited by 164
Self-citationvan Doorninck, J., Ji, L., Schaub, B., Shimada, H., Wing, M. R., Krailo, M., Lessnick, S. L., Marina, N. M., Triche, T. J., Sposto, R., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.5845 · Cited by 152
Self-citationKailayangiri, S., Altvater, B., Meltzer, J., Pscherer, S., Luecke, A., Dierkes, C., Titze, U., Leuchte, K., Landmeier, S., Hotfilder, M., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.57 · Cited by 146
Self-citationCohen‐Gogo, S., Cellier, C., Coindre, J., Mosseri, V., Pierron, G., Guillemet, C., Italiano, A., Brugières, L., Orbach, D. H., Laurence, V., et al. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25210 · Cited by 133
Self-citationOberlin, O., Rey, A., Defachelles, A. S., Philip, T. O., Plantaz, D., Schmitt, C., Plouvier, E., Lejars, O., Rubie, H., Terrier, P., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.7059 · Cited by 131
Self-citationEcteinascidin 743 Interferes with the Activity of EWS-FLI1 in Ewing Sarcoma Cells
Grohar, P. J., Griffin, L. B., Yeung, C. L., Chen, Q.-R., Pommier, Y. G., Khanna, C., Khan, J. I., & Helman, L. J. (2011) · Neoplasia · doi:10.1593/neo.101202 · Cited by 130
Ferrari, S., Hall, K. S., Luksch, R., Tienghi, A., Wiebe, T., Fagioli, F., Alvegård, T. A., del Prever, A. B., Tamburini, A., Alberghini, M., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq573 · Cited by 126
Self-citationFox, E., PATEL, S. R., Wathen, J. K., Schuetze, S. M., Chawla, S. P., Harmon, D. C., Reinke, D. K., Chugh, R. K., Benjamin, R. S., & Helman, L. J. (2012) · The Oncologist · doi:10.1634/theoncologist.2010-0265 · Cited by 120
Nesbit, M. E., Perez, C. A., Tefft, M., Burgert, E. O., Tj, V., Kissane, J. M., Dj, P., & Gehan, E. A. (1981) · PubMed · Cited by 111
Fagnou, C., Michon, J. M., Peter, M., Bernoux, A., Oberlin, O., Zucker, J. M., Magdelénat, H., & Delattre, O. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1707 · Cited by 108
Self-citationLuksch, R., Tienghi, A., Hall, K. S., Fagioli, F., Picci, P., Barbieri, E., Gandola, L., Eriksson, M., Ruggieri, P., Daolio, P. A., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds117 · Cited by 105
Self-citationZoubek, A., Ladenstein, R. L., Windhager, R., Amann, G., Fischmeister, G., Kager, L., Jugović, D., Ambros, P. F., Gadner, H., & Kovar, H. (1998) · International Journal of Cancer · Cited by 99
Self-citationOberlin, O., Habrand, J., Zucker, J. M., Brunat-Mentigny, M., Terrier-Lacombe, M.-J., Dubousset, J., Gentet, J. C., Schmitt, C., Ponvert, D., & Carrié, C. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.9.1407 · Cited by 98
Self-citationShankar, A., Pinkerton, R., Atra, A., Ashley, S. E., Lewis, I. J., Spooner, D. A., Cannon, S. R., Grimer, R. J., Cotterill, S. J., & Craft, A. W. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00144-6 · Cited by 93
Self-citationEqual quality of life after limb-sparing or ablative surgery for lower extremity sarcomas
Zahlten‐Hinguranage, A., Bernd, L., Ewerbeck, V., & Sabo, D. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602104 · Cited by 90
The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors
Avigad, S., Cohen, I. J., Zilberstein, J., Liberzon, E., Goshen, Y., Ash, S., Meller, I., Kollender, Y., Issakov, J., Zaizov, R., et al. (2004) · Cancer · doi:10.1002/cncr.20059 · Cited by 84
Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients
Odri, G. A., Dumoucel, S., Picarda, G. G. A., Battaglia, S., Lamoureux, F., Corradini, N., Rousseau, J., Tirode, F., Laud, K., Delattre, O., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4272 · Cited by 84
Self-citationTargeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth
Surdez, D., Benetkiewicz, M., Perrin, V., Han, Z., Pierron, G., Ballet, S., Lamoureux, F., Rédiní, F., Decouvelaere, A., Daudigeos‐Dubus, E., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0371 · Cited by 80
Self-citationBoro, A., Prêtre, K., Rechfeld, F., Thalhammer, V., Oesch, S., Wachtel, M., Schäfer, B. W., & Niggli, F. K. (2012) · International Journal of Cancer · doi:10.1002/ijc.27472 · Cited by 72
Womer, R. B., Daller, R., Fenton, J. G., & Miser, J. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00236-1 · Cited by 72
Self-citationDuBois, S. G., Krailo, M., Lessnick, S. L., Smith, R. A., Chen, Z., Marina, N. M., Grier, H. E., & Stegmaier, K. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21822 · Cited by 70
Response to high‐dose ifosfamide in patients with advanced/recurrent Ewing sarcoma
Ferrari, S., del Prever, A. B., Palmerini, E., Staals, E. L., Berta, M., Balladelli, A., Picci, P., Fagioli, F., Bacci, G., & Vanel, D. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.21917 · Cited by 67
Self-citationThe role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis
Domingo-Fernandéz, R., Watters, K. M., Piskareva, O., Stallings, R. L., & Bray, I. M. (2012) · Pediatric Surgery International · doi:10.1007/s00383-012-3239-7 · Cited by 65
Felgenhauer, J. L., Nieder, M. L., Krailo, M., Bernstein, M. L., Henry, D. W., Malkin, D. M., Baruchel, S., Chuba, P. J., Sailer, S. L., Brown, K., et al. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24328 · Cited by 64
Self-citationde Álava, E., Lozano, M. D., Patiño‐García, A., Sierrasesúmaga, L., & Pardo-Mindán, F. J. (1998) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199806000-00005 · Cited by 62
The value of high‐dose chemotherapy in patients with first relapsed Ewing sarcoma
Rasper, M., Jabar, S., Ranft, A., Jürgens, H., Amler, S., & Dirksen, U. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25042 · Cited by 61
Self-citationMcTiernan, A., Driver, D., Michelagnoli, M. P., Kilby, A. M., & Whelan, J. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl108 · Cited by 61
Self-citationLerman, D. M., Monument, M. J., McIlvaine, E. J., Liu, X., Huang, D., Monovich, L., Beeler, N., Gorlick, R. G., Marina, N. M., Womer, R. B., et al. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25340 · Cited by 60
Self-citationPrognostic factors in surgery for pulmonary metastases in children.
Heij, H. A., Vos, A., de Kraker, J., & Voûte, P. A. (1994) · PubMed · Cited by 58
Garofalo, C., Mancarella, C., Grilli, A., Manara, M. C., Astolfi, A., Marino, M. T., Conte, A., Sigismund, S., Carè, A., Belfiore, A., et al. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1142 · Cited by 57
Self-citationThe ups and downs of DNA repair biomarkers for PARP inhibitor therapies.
Wang, X., & Weaver, D. T. (2011) · Europe PMC (PubMed Central) · Cited by 54
Shukla, N. N., Schiffman, J. D., Reed, D. R., Davis, I. J., Womer, R. B., Lessnick, S. L., & Lawlor, E. R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00141 · Cited by 46
Self-citationThe role of megatherapy with autologous bone marrow rescue in solid tumours of childhood
Ladenstein, R. L., Hartmann, O., & Pinkerton, R. (1993) · Annals of Oncology · doi:10.1093/annonc/4.suppl_1.s45 · Cited by 39
Self-citationThe First European Interdisciplinary Ewing Sarcoma Research Summit
Kovar, H., Alonso, J., Åman, P., Aryee, D. N. T., Ban, J., Burchill, S. A., Burdach, S. E. G., de Álava, E., Delattre, O., Dirksen, U., et al. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00054 · Cited by 38
Self-citationBone Sarcomas: From Biology to Targeted Therapies
Gaspar, N., Giannatale, A. D., Geoerger, B., Rédiní, F., Corradini, N., Entz‐Werlé, N., Tirode, F., Marec‐Bérard, P., Gentet, J., Laurence, V., et al. (2012) · Sarcoma · doi:10.1155/2012/301975 · Cited by 31
Self-citationNovel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors
Erkizan, H. V., Scher, L., Gamble, S. E., Barber-Rotenberg, J. S., Sajwan, K. P., Üren, A., & Toretsky, J. A. (2011) · Cell Cycle · doi:10.4161/cc.10.19.17734 · Cited by 29
Cited by
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Self-citationCasali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy310 · Cited by 617
Self-citationSarcoma treatment in the era of molecular medicine
Grünewald, T. G., Alonso, M., Avnet, S., Banito, A., Burdach, S., Cidre‐Aranaz, F., Di Pompo, G., Distel, M., Dorado‐Garcia, H., Garcia‐Castro, J., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911131 · Cited by 319
Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives
Zöllner, S. K., Amatruda, J. F., Bauer, S., Collaud, S., de Álava, E., DuBois, S. G., Hardes, J., Hartmann, W., Kovar, H., Metzler, M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081685 · Cited by 271
Self-citationPeneder, P., Stütz, A. M., Surdez, D., Krumbholz, M., Semper, S., Chicard, M., Sheffield, N. C., Pierron, G., Lapouble, E., Tötzl, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23445-w · Cited by 200
Self-citation
Metadata
- Authors
- Gaspar, N., Hawkins, D. S., Dirksen, U., Lewis, I. J., Ferrari, S., Le Deley, M.-C., Kovar, H., Grimer, R., Whelan, J., Claude, L., Delattre, O., Paulussen, M., Picci, P., Sundby Hall, K., van den Berg, H., Ladenstein, R., Michon, J., Hjorth, L., Judson, I., Luksch, R., Bernstein, M. L., Marec-Bérard, P., Brennan, B., Craft, A. W., Womer, R. B., Juergens, H., & Oberlin, O.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-09-20
- Volume
- 33
- Issue
- 27
- Pages
- 3036-3046
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2164559547
- Cited by
- 722
- References
- 72
- FWCI
- 35.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.